Safety And Efficacy Study Of CP-675,206 In HIV-Infected Patients

Summary

The purpose of this study is to determine if CP-675,206, a monoclonal antibody to CTLA4, is safe and well-tolerated, reduces viral load, and improves immune function in patients infected with HIV.

Timeline

Start

2007-07

Primary completion

—

Completion

—

Drugs

Indications